Fig. 2
TGF-β Signaling Is Required during PAA Progenitor Differentiation (A–L) Stage-specific LY-364947 exposure reveals a requirement for TGF-β signaling after PAA progenitor specification. (A) Schematic diagram showing drug treatment regimens designed to inhibit TGF-β signaling during (10–16 hr post-fertilization; hpf) and/or after (+16 hpf) progenitor specification. (B–K) Left lateral views of tie1+ PAA angioblast clusters in 36-hpf embryos treated during the indicated developmental windows with DMSO or 50 μM LY-364947. The angioblast clusters that did form in LY-364947-treated embryos appeared smaller and/or failed to sprout (asterisks in H, J, and K). Scale bars, 200 μm. (L) Bar graph showing the average number of tie1+ angioblast clusters ±SD within each experimental group (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001). n = 20–50 embryos per treatment group with a total of three biological replicates. |
Gene: | |
---|---|
Fish: | |
Condition: | |
Anatomical Terms: | |
Stage: | Prim-25 |
Fish: | |
---|---|
Condition: | |
Observed In: | |
Stage: | Prim-25 |